A Special Issue, “School Psychopharmacology and Children’s Mental Health,” has been planed for in Children (ISSN 2227-9067, https://www.mdpi.com/journal/children). As such, the journal invites submissions of original research and/or review article on the topic of school psychopharmacology.

Benefits of publishing with Children:

  1. Open access. Unlimited and free access to readers increases publicity and promotes more frequent citations, as indicated by several studies.
  2. High visibility and impact. Children is indexed by the leading indexing services, like Scopus, SCIE, PubMed, and NCBI, and has an updated Impact Factor of 2.863 (+37% compared with the previous year).
  3. Rapid publication times combined with thorough peer review. The average whole processing period from submission to publication is about 35 days.

Papers may be submitted from now until 15 January 2023 and will be published on an ongoing basis within the special issue. An Article Processing Charge (APC) of CHF 1800 currently applies to all accepted papers. You may be entitled to a discount as you receive this invitation. If this is of interest, and you would like to explore a discount ahead of formal submission, you are welcome to send a tentative title to the Editorial Office Ms. Malinda Jiang (malinda.jiang@mdpi.com and cc: me at carlsoj@msu.edu). They will check the suitability and steps necessary to secure a partial or full waiver.

If you have questions about whether your manuscript idea might be a good link to the special issue, please contact Guest Editor John S. Carlson (carlsoj@msu.edu).